hUMSC-derived exosomal miR-486-5p alleviates spinal cord injury by activating AKT/mTOR pathway
Background
Spinal Cord Injury (SCI) is a devastating central nervous system disorder leading to irreversible motor dysfunction, with current treatments offering limited efficacy. The secondary injury cascade, involving inflammation and apoptosis, significantly contributes to long-term neurological deficits. Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs), particularly exosomes, have emerged as promising therapeutic carriers due to their ability to mediate intercellular communication and deliver neuroprotective microRNAs (miRNAs). This study investigates the specific role of exosomal miR-486-5p from human umbilical cord MSCs (hUMSCs) in mitigating SCI pathology.
Study Design
Researchers established both a rat SCI model and an LPS-induced PC12 cell inflammatory injury model to investigate the effects of hUMSC-derived exosomes. Exosomes were isolated from hUMSCs and characterized using transmission electron microscopy, nanoparticle tracking analysis, and exosomal marker expression. Histological injury and apoptosis were assessed via HE staining and TUNEL assay in vivo. Inflammatory cytokine levels were quantified by ELISA. In vitro, cell viability, apoptosis, and gene/protein expression were evaluated using CCK-8 assay, flow cytometry, qPCR, and western blotting. A dual-luciferase reporter assay validated the direct interaction between miR-486-5p and PTEN's 3'-UTR.
Results
hUMSC-derived exosomes significantly attenuated spinal cord tissue damage, reduced neuronal apoptosis, and suppressed inflammatory cytokine production in both the in vivo rat SCI model and the in vitro LPS-induced PC12 cell model. These protective effects were partially reversed by inhibiting exosomal miR-486-5p, highlighting its crucial role. Mechanistically, miR-486-5p was found to directly target the 3'-UTR of the tumor suppressor gene PTEN, leading to a decrease in PTEN expression. This reduction in PTEN subsequently resulted in enhanced phosphorylation of AKT and mTOR, indicating activation of the PI3K/AKT/mTOR signaling pathway. This pathway activation is known to promote cell survival and inhibit inflammation. The findings collectively demonstrate that exosomal miR-486-5p from hUMSCs modulates apoptosis- and inflammation-associated molecular events following SCI.
hUMSC-derived exosomal miR-486-5p directly targets PTEN, leading to its reduced expression and subsequent activation of the PI3K/AKT/mTOR pathway, which mitigates SCI-induced apoptosis and inflammation.
Key Findings
- hUMSC-derived exosomes attenuated spinal cord tissue damage in a rat SCI model.
- Exosomes reduced neuronal apoptosis and suppressed inflammatory cytokine production both in vivo and in vitro.
- Inhibition of exosomal miR-486-5p partially reversed these protective effects.
- miR-486-5p directly targeted the 3'-UTR of PTEN, reducing its expression.
- Reduced PTEN expression led to enhanced phosphorylation of AKT and mTOR, activating the PI3K/AKT/mTOR pathway.
Why It Matters
This research provides a crucial mechanistic understanding of how hUMSC-derived exosomes exert neuroprotective effects in Spinal Cord Injury, specifically identifying miR-486-5p as a key therapeutic component. For peptide users and biohackers interested in regenerative medicine, this highlights a specific miRNA and its pathway (PTEN/AKT/mTOR) as a potential target for future interventions. While not yet a usable protocol, these insights could guide the development of exosome-based therapies or gene therapies designed to deliver miR-486-5p or modulate the PTEN pathway. Targeting miR-486-5p or the PTEN/AKT/mTOR axis could offer a novel strategy to reduce inflammation and neuronal cell death post-SCI, potentially improving outcomes beyond current standards of care. Further research is needed to translate these findings into clinical applications, including optimal exosome dosing and delivery methods.
spinal-cord-injury
msc-evs
mir-486-5p
neuroprotection
inflammation
apoptosis